• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Heart Health Ingredients - Global Strategic Business Report Product Image

Heart Health Ingredients - Global Strategic Business Report

  • ID: 2255344
  • August 2012
  • Region: Global
  • 456 Pages
  • Global Industry Analysts, Inc

This report analyzes the worldwide markets for Heart Health Ingredients in US$ Million by the following Product Segments: Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2018. Also, a six-year historic analysis is provided for these markets.

The report profiles 56 companies including many key and niche players such as Archer Daniels Midland Company, BASF SE, BioActives, LLC, Biovelop AB, Cargill, Inc., Cyanotech Corporation, DSM Nutritional Products Limited, Glanbia Nutritionals, Inc., Lonza Group Limited, LycoRed Limited, Martek Biosciences Corporation, Novus Nutrition Brands, LLC, Ocean Nutrition Canada Limited, Omega Protein Corporation, Pharmachem Laboratories, Inc., Proprietary Nutritionals, Inc., Raisio plc, Solae Europe, S.A., Soy Labs, LLC, and Valensa International, LLC.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Omega-3 PUFA I-3
Soy Protein I-3
Phytosterols I-4
Beta-Glucagons I-4
Other Heart Health Ingredients I-4

II. Executive Summary

1. INDUSTRY OVERVIEW II-1
Health Consciousness Driving the Market for Functional Foods II-1
Future Growth Stimulators II-2
Research & Development: Determines the Future of Health
Ingredients II-2
Current & Future Analysis II-2
Market Trends II-2
Cardiovascular Disorders - The Leading Cause for Flourishing
Heart Health Ingredients Market II-2
“Heart Health” Growing on a Healthy Note II-3
PUFA - A Part of Regular Diet II-3
Omega-3 Fatty Acids Adding Flavor to Heart Health
Ingredients Markets II-3
Lucrative Prospects Call for a Flood of New Entrants II-4
Phytosterols Market on a Growth Trajectory II-4
Natural Ingredients - The In thing II-4
Nutrition Science: An Evolutionary Proof II-5
Health Claims on Snacks - Opportunity Galore II-5
Asia Pacific - A Threat to Established Markets II-5
Omega-3 Market in Asia-Pacific Expected to Witness Robust
Growth Momentum II-5
Soy Protein Dominates Global Heart Health Ingredients Market II-6
Soy Foods & Beverages: A Boon II-6
Aging Population Propels Soyfood Sales II-6
Vitamin Enriched Products: Boosting Market Growth II-6
Natural Vitamin E - A Cross-Sectional Exposition II-6
Stumbling Blocks II-7
Major Growth Delimiters II-7
Regulation Issues II-7
Key Statistics II-8
Table 1: Leading Beverage Launches with Heart Health Claims
(2011): Percentage Share Breakdown for Dairy Drinks, Tea,
Dairy Alternative Drinks and Others (includes corresponding
Graph/Chart) II-8

Table 2: Leading Heart Health Ingredients in Global Market
(2011): Percentage Breakdown for Vitamin E, Phytosterols, Soy
Protein, Magnesium, Niacin, Omega-3, Flaxseed and Others in
Beverage Launches with Heart Health Claims (includes
corresponding Graph/Chart) II-8

2. OVERVIEW OF CARDIOVASCULAR DISEASES II-9
CVD - Global Facts II-9
Table 3: Leading Countries with Total Deaths due to
Cardiovascular Diseases for 65+ Population by Sex in
Thousands for the Year 2008 (includes corresponding
Graph/Chart) II-9

Table 4: Percentage Share of Deaths for 65+ Population due
to Heart Diseases by Disease Type for Ischaemic,
Cerebrovascular, Hypertensive, Inflammatory and Rheumatic in
2008 (includes corresponding Graph/Chart) II-10

3. PRODUCT OVERVIEW II-11
Introduction II-11
Functional Foods - Definition II-11
What are Heart Health Ingredients? II-11
Food Components and Heart Health Benefit(s) II-12
Select Heart Health Ingredients II-12
Omega-3 PUFA II-12
Soy Protein II-12
Soy Protein Concentrate II-13
Soy Protein Isolates II-13
Textured Soy Protein (TSP) II-14
Phytosterols II-14
Table 5: Phytosterol Content in Select Products II-14
Beta-Glucagons II-15
Other Heart Health Ingredients II-15
Psyllium (Fiber) II-15
Coenzyme Q10 II-15
Vitamin C and E II-16
Carotenoids II-16
Astaxanthin II-16
Beta-Carotene II-16
Lutein II-16
Lycopene II-17
Niacin II-17
Vitamin K2 II-17
Potassium II-17
Magnesium II-17
Selenium II-18
Vitamin B12 and Folic Acid II-18

4. PRODUCT LAUNCHES II-19
Oatworks Unveils New Oat-and-Fruit Smoothies Line II-19
Morinda Bioactives Commences Shipments of New Fit Body
Composition Supplements II-19
Danisco Launches PinVita Phytosterols II-19
Danone Releases Danacol® Yoghurt in Canada II-19
DSM Nutritional Products to Unveil lifesDHA™ II-20
ImmunoMedic Introduces Betox-93™ Glucan Ingredient II-20
Nordic Naturals Launches Omega-3 Effervescent II-20
Frutarom Rolls Out Benolea® Olive Leaf Extract II-20
Fortitech Europe Unveils Premixes for Energy, Sports and
Heart Health Nutrition II-21
Sabinsa Launches pTeroWhite® and Silbinol® Ingredients II-21
Oatly to Launch Oatly Fresh Drink II-21
Solbar Unveils Bontex Soy Proteins in France II-22
Stratum Nutrition Introduces ARTINIA™ II-22
Valensa International and Aker BioMarine Co-Launch Deep Ocean
Krill Ingredient II-23
Sara Lee Introduces Sara Lee Soft & Smooth Plus Made with DHA
Omega-3 for Kids II-23
Hormel Foods Introduces Omega-3/CoQ10 Combination Ingredient II-23
Solae Europe Unveils FIBRIM 1270 II-23
Biovelop Introduces PromOat™ II-24
DSM Nutritional Products Showcases Heart Health Ingredients II-24
Cargill Unveils Clear Valley II-24
Triarco Industries Launches Aqua 10® II-25
Ocean Nutrition Canada Introduces MEG-3® Dry Powder II-25
Valensa International Introduces Omega Joe ALA II-25
Parmalat Canada Unveils Astro BioBest Plant Sterols Yoghurt
in Canada II-25
Cargill Launches Vitafusion HeartOne Gummy Vitamins II-26
Adam Food Ingredients Launches Range of Nutritional
Ingredients II-26
Bayer Consumer Care Introduces Citracal Calcium Plus Heart
Health II-26
Carbery Ingredients Unveils Omega-3/WPC Blend II-26
BioActives Unveils Cardio HB Ingredient II-26
Kashi Company Launches Plant Sterol-Fortified Crackers II-27
Proprietary Nutritional Introduces Microencapsulated Version
of Omega-3 Ingredients II-27
Cyanotech Introduces Hawaiian Spirulina Pacifica Multivitamin
Range II-27
Forbes Medi-Tech Launches Reducol™-Fortified Pineapple Juice
in the Philippines II-28
Mitake Food Develops Beta Glucan Rich Flour II-28
Natunola Health Biosciences Introduces Natunola® healths
delight Omega-3 Instant Oatmeal with Shelled Flax II-28
Cargill Unveils Heart Health Products II-28
Soy Labs Introduces Lunasin-based Ingredients II-29

5. RECENT INDUSTRY ACTIVITY II-30
DuPont Takes Over Solae II-30
BASF Acquires Equateq II-30
CHS Takes Over Solbar Industries II-30
Stratum Nutrition Enters into Exclusive Partnership with
Phytonet II-31
Enzymotec Receives Patent for Omega-Sterols in Australia II-31
Atrium Innovations Acquires Minami Nutrition II-31
Lactalis Iberia Purchases Stake in Biosearch Life Division of
Ebro Foods II-31
Royal DSM Purchases Martek Biosciences II-32
Stepan Company Takes Over Certain Product Lines of Lipid
Nutrition II-32
Danisco BioActives Inks Long-Term Agreement with Arboris II-32
Biovelop Inks Distribution Agreement with Quadra Chemicals II-33
Corazonas Foods Enters into Partnership with Cargill II-33
Biovelop Inks Distribution Agreement with CJP Chemicals II-33
Stratum Nutrition Enters into Exclusive Partnership with CK
Nutritional Ingredients II-34
Valens Secures Positive EFSA Opinion for Reduchol II-34
Scoular Signs Distribution Agreement with Soy Labs II-34
Smart Balance Selects CoroWise Plant Phytosterols by Cargill
for Heart Right Milk II-34
Proprietary Nutritionals Substantiates Advertising Claims for
Sytrinol Product II-34
Cargill and BASF Enter into Partnership to Develop Plant-
Based Omega-3 Oils II-35
Hans-Günter Berner Chooses PromOat™ Beta Glucan from Biovelop
for Cellagon Aurum® II-35
Genosa Receives Positive Claim from EFSA Panel II-36
Mannatech Concludes Reformulation of Omega-3 Supplements II-36
Stratum Nutrition Secures Generally Recognized As Safe
Designation for ARTINIA Fiber Ingredient II-36
Provexis and DSM Nutritional Products Ink Development
Agreement for Casein Ingredient II-36
ADM Inks Global Licensing Deal with Burcon NutraScience II-37
Omega Protein Takes Over Cyvex Nutrition II-37
BASF Purchases Cognis Holding II-37
Pharmachem Laboratories Buys Forbes Medi-Tech II-37
Solazyme Inks Joint Venture Agreement with Roquette Frères II-38
Stratum Nutrition and Kitozyme Enter into Partnership II-38
Ceapro Inks Distribution and License Agreement with Oat
Cosmetics II-38
Martek Biosciences Signs Agreement with Mengniu II-39
Novus International Establishes Stratum Nutrition Division II-39
Cognis Licenses Product Candidates from InterMed Discovery II-39
Neptune Technologies' Bioressources Receive EFSA Approval for
Neptune Krill Oil II-39

6. FOCUS ON SELECT GLOBAL PLAYERS II-40
Archer Daniels Midland Company (US) II-40
BASF SE (Germany) II-40
BioActives, LLC (US) II-41
Biovelop AB (Sweden) II-41
Cargill, Inc. (US) II-42
Cyanotech Corporation (US) II-42
DSM Nutritional Products Limited (Switzerland) II-43
Glanbia Nutritionals, Inc. (US) II-43
Lonza Group Limited (Switzerland) II-44
LycoRed Limited (Israel) II-44
Martek Biosciences Corporation (US) II-45
Novus Nutrition Brands, LLC (US) II-45
Ocean Nutrition Canada Limited (Canada) II-46
Omega Protein Corporation (US) II-46
Pharmachem Laboratories, Inc. (US) II-47
Proprietary Nutritionals, Inc. (US) II-47
Raisio plc (Finland) II-47
Solae Europe, S.A. (Switzerland) II-48
Soy Labs, LLC (US) II-48
Valensa International, LLC (US) II-49

7. GLOBAL MARKET PERSPECTIVE II-50
Table 6: World Recent Past, Current and Future Analysis for
Heart Health Ingredients by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), and Rest of
World Markets Independently Analyzed with Annual Sales in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) II-50

Table 7: World Historic Review for Heart Health Ingredients
by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) II-51

Table 8: World 15-Year Perspective for Heart Health
Ingredients by Geographic Region - Percentage Breakdown of
Dollar Sales for Markets for US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World for Years
2004, 2011 & 2018 (includes corresponding Graph/Chart) II-52

Table 9: World Recent Past, Current and Future Analysis for
Omega-3 PUFA by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) II-53

Table 10: World Historic Review for Omega-3 PUFA by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), and Rest of World Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) II-54

Table 11: World 15-Year Perspective for Omega-3 PUFA by
Geographic Region - Percentage Breakdown of Dollar Sales for
Markets for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), and Rest of World for Years 2004, 2011 & 2018
(includes corresponding Graph/Chart) II-55

Table 12: World Recent Past, Current and Future Analysis for
Soy Protein by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2010 through 2018 (includes corresponding Graph/Chart) II-56

Table 13: World Historic Review for Soy Protein by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), and Rest of World Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) II-57

Table 14: World 15-Year Perspective for Soy Protein by
Geographic Region - Percentage Breakdown of Dollar Sales for
Markets for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World for Years 2004, 2011 &
2018 (includes corresponding Graph/Chart) II-58

Table 15: World Recent Past, Current and Future Analysis for
Phytosterols by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) II-59

Table 16: World Historic Review for Phytosterols by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), and Rest of World Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) II-60

Table 17: World 15-Year Perspective for Phytosterols by
Geographic Region - Percentage Breakdown of Dollar Sales for
Markets for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World for Years 2004, 2011 &
2018 (includes corresponding Graph/Chart) II-61

Table 18: World Recent Past, Current and Future Analysis for
Beta-Glucagon by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) II-62

Table 19: World Historic Review for Beta-Glucagon by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) II-63

Table 20: World 15-Year Perspective for Beta-Glucagon by
Geographic Region - Percentage Breakdown of Dollar Sales for
Markets for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World for Years 2004, 2011 &
2018 (includes corresponding Graph/Chart) II-64

Table 21: World Recent Past, Current and Future Analysis for
Other Heart Health Ingredients by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-65

Table 22: World Historic Review for Other Heart Health
Ingredients by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) II-66

Table 23: World 15-Year Perspective for Other Heart Health
Ingredients by Geographic Region - Percentage Breakdown of
Dollar Sales for Markets for US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World for Years
2004, 2011 & 2018 (includes corresponding Graph/Chart) II-67

III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current & Future Analysis III-1
US Heart Health Market Driven by Approvals III-1
Increasing Number of Ingredients Qualify for Health Claims III-1
Table 24: Leading Heart Health Ingredients in US Market
(2011): Percentage Breakdown for Vitamin E, Magnesium,
Omega-3, Grape Seed Extract, Phytosterols, Soy Protein and
Others in Beverage Launches with Heart Health Claims
(includes corresponding Graph/Chart) III-2
Factors Driving Growth III-2
Market Inhibitors III-3
Cardiovascular Diseases Scenario III-3
Table 25: Leading Causes of Death in the US (2008):
Percentage Share Breakdown by Disease for Heart Disease,
Cancer, Chronic Lower Respiratory Diseases,
Cerebrovascular Diseases (Stroke), Alzheimer's Disease and
Others (includes corresponding Graph/Chart) III-3

Table 26: Deaths from Cardiovascular Diseases in the US
(2008): Percentage Share Breakdown by Disease for CHD,
Stroke, Hypertensive Diseases, Heart Failure (Underlying),
Diseases of Arteries and Other CVD (includes corresponding
Graph/Chart) III-4

Table 27: Prevalence of Cardio Vascular Diseases in the US
(2008): Percentage Share Breakdown by Disease for
Hypertension, CHD, Angina Pectoris, Peripheral Arterial
Disease, Acute Myocardial Infarction (AMI), Stroke, Heart
Failure, Atrial Fibrillation and Congenital Heart Defects
(includes corresponding Graph/Chart) III-4

Table 28: Economic Cost on Cardiovascular Diseases in the
US (2008): Expenditure for Direct and Mortality in US$
Billion (includes corresponding Graph/Chart) III-5
Regulatory Environment III-5
Food and Drug Administration (FDA) III-5
Generally Recognized As Safe (GRAS) III-5
Consumer Health Information for Better Nutrition
Initiative (CHIBNI) III-6
Dietary Supplement Health and Education Act (DSHEA) III-6
Functional Foods and Dietary Supplements: Comparison of
Regulations III-7
Federal Trade Commission (FTC) III-7
Nutrition Labeling and Education Act (NLEA) III-7
FDA Modernization Act (FDAMA) III-8
Product Launches III-8
Strategic Corporate Developments III-13
Key Players III-18
B.Market Analytics III-24
Table 29: US Recent Past, Current and Future Analysis for
Heart Health Ingredients by Product Segment - Omega-3 PUFA,
Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart
Health Ingredients Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-24

Table 30: US Historic Review for Heart Health Ingredients by
Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols,
Beta-Glucagon, and Other Heart Health Ingredients Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-25

Table 31: US 15-Year Perspective for Heart Health
Ingredients by Product Segment - Percentage Breakdown of
Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols,
Beta-Glucagon, and Other Heart Health Ingredients Markets
for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-26

2. CANADA III-27
A.Market Analysis III-27
Current & Future Analysis III-27
Regulatory Scenario III-27
Definition III-27
Food and Drugs Act and Health Canada III-27
Natural Health Product Regulations III-28
Product Launches III-28
Strategic Corporate Developments III-29
Ocean Nutrition Canada Limited - A Major Omega-3 Dha/Eha
Supplier in Canada III-30
B.Market Analytics III-31
Table 32: Canadian Recent Past, Current and Future Analysis
for Heart Health Ingredients by Product Segment - Omega-3
PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other
Heart Health Ingredients Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-31

Table 33: Canadian Historic Review for Heart Health
Ingredients by Product Segment - Omega-3 PUFA, Soy Protein,
Phytosterols, Beta-Glucagon, and Other Heart Health
Ingredients Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-32

Table 34: Canadian 15-Year Perspective for Heart Health
Ingredients by Product Segment - Percentage Breakdown of
Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols,
Beta-Glucagon, and Other Heart Health Ingredients Markets
for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-33

3. JAPAN III-34
A.Market Analysis III-34
Current & Future Analysis III-34
Outlook III-34
Growth Drivers III-34
Regulatory Environment III-35
Definition III-35
FOSHU (Foods For Specified Health Uses) III-35
B.Market Analytics III-36
Table 35: Japanese Recent Past, Current and Future Analysis
for Heart Health Ingredients by Product Segment - Omega-3
PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other
Heart Health Ingredients Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-36

Table 36: Japanese Historic Review for Heart Health
Ingredients by Product Segment - Omega-3 PUFA, Soy Protein,
Phytosterols, Beta-Glucagon, and Other Heart Health
Ingredients Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-37

Table 37: Japanese 15-Year Perspective for Heart Health
Ingredients by Product Segment - Percentage Breakdown of
Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols,
Beta-Glucagon, and Other Heart Health Ingredients Markets
for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-38

4. EUROPE III-39
A.Market Analysis III-39
Current & Future Analysis III-39
Analysis by Country/Region III-39
Analysis by Product Segment III-39
Market Overview III-39
Changing Demographics to Propel Market Growth III-39
Growth Drivers III-40
Growth Restraints III-40
Heart Health - The New Functional Dairy Target III-40
Death Rate Due to CVD III-41
Table 38: Leading European Countries with Deaths due to
Cardiovascular Diseases for the Year 2009 (Deaths per
100,000 Inhabitants) (includes corresponding Graph/Chart) III-41
Regulatory Scenario III-41
European Food Safety Authority (EFSA) III-41
Hydroxytyrosol Bags Health Claim Approval from EFSA III-42
B.Market Analytics III-43
Table 39: European Recent Past, Current and Future Analysis
for Heart Health Ingredients by Country/Region - France,
Germany, Italy, UK, and Rest of Europe Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-43

Table 40: European Historic Review for Heart Health
Ingredients by Country/Region - France, Germany, Italy, UK,
and Rest of Europe Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-44

Table 41: European 15-Year Perspective for Heart Health
Ingredients by Country/Region - Percentage Breakdown of
Dollar Sales for France, Germany, Italy, UK, and Rest of
Europe Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-45

Table 42: European Recent Past, Current and Future Analysis
for Heart Health Ingredients by Product Segment - Omega-3
PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other
Heart Health Ingredients Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-46

Table 43: European Historic Review for Heart Health
Ingredients by Product Segment - Omega-3 PUFA, Soy Protein,
Phytosterols, Beta-Glucagon, and Other Heart Health
Ingredients Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-47

Table 44: European 15-Year Perspective for Heart Health
Ingredients by Product Segment - Percentage Breakdown of
Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols,
Beta-Glucagon, and Other Heart Health Ingredients Markets
for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-48

4a. FRANCE III-49
A.Market Analysis III-49
Current & Future Analysis III-49
High Incidence of ‘Bad' Cholesterol Pumps Sales of
Functional Fats III-49
Product Launch III-49
B.Market Analytics III-50
Table 45: French Recent Past, Current and Future Analysis
for Heart Health Ingredients by Product Segment - Omega-3
PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other
Heart Health Ingredients Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-50

Table 46: French Historic Review for Heart Health
Ingredients by Product Segment - Omega-3 PUFA, Soy Protein,
Phytosterols, Beta-Glucagon, and Other Heart Health
Ingredients Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-51

Table 47: French 15-Year Perspective for Heart Health
Ingredients by Product Segment - Percentage Breakdown of
Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols,
Beta-Glucagon, and Other Heart Health Ingredients Markets
for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-52

4b. GERMANY III-53
A.Market Analysis III-53
Current & Future Analysis III-53
Strategic Corporate Developments III-53
BASF SE - A Major German Player III-54
B.Market Analytics III-56
Table 48: German Recent Past, Current and Future Analysis
for Heart Health Ingredients by Product Segment - Omega-3
PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other
Heart Health Ingredients Markets Independently Analyzed
with Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-56

Table 49: German Historic Review for Heart Health
Ingredients by Product Segment - Omega-3 PUFA, Soy Protein,
Phytosterols, Beta-Glucagon, and Other Heart Health
Ingredients Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-57

Table 50: German 15-Year Perspective for Heart Health
Ingredients by Product Segment - Percentage Breakdown of
Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols,
Beta-Glucagon, and Other Heart Health Ingredients Markets
for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-58

4c. ITALY III-59
Market Analysis III-59
Table 51: Italian Recent Past, Current and Future Analysis
for Heart Health Ingredients by Product Segment - Omega-3
PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and Other
Heart Health Ingredients Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-60

Table 52: Italian Historic Review for Heart Health
Ingredients by Product Segment - Omega-3 PUFA, Soy Protein,
Phytosterols, Beta-Glucagon, and Other Heart Health
Ingredients Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-61

Table 53: Italian 15-Year Perspective for Heart Health
Ingredients by Product Segment - Percentage Breakdown of
Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols,
Beta-Glucagon, and Other Heart Health Ingredients Markets
for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-62

4d. THE UNITED KINGDOM III-63
A.Market Analysis III-63
Current & Future Analysis III-63
Rising Health Concerns Make Consumers Clamor for Functional
Foods III-63
Growth Drivers III-63
Growth Restraints III-63
Regulatory Environment III-64
Product Launch III-64
Strategic Corporate Development III-64
B.Market Analytics III-65
Table 54: UK Recent Past, Current and Future Analysis for
Heart Health Ingredients by Product Segment - Omega-3 PUFA,
Soy Protein, Phytosterols, Beta-Glucagon, and Other Heart
Health Ingredients Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-65

Table 55: UK Historic Review for Heart Health Ingredients by
Product Segment - Omega-3 PUFA, Soy Protein, Phytosterols,
Beta-Glucagon, and Other Heart Health Ingredients Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-66

Table 56: UK 15-Year Perspective for Heart Health
Ingredients by Product Segment - Percentage Breakdown of
Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols,
Beta-Glucagon, and Other Heart Health Ingredients Markets
for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-67

4e. REST OF EUROPE III-68
A.Market Analysis III-68
Current & Future Analysis III-68
Product Launches III-68
Strategic Corporate Developments III-71
Focus on Select Regional Players III-73
B.Market Analytics III-76
Table 57: Rest of Europe Recent Past, Current and Future
Analysis for Heart Health Ingredients by Product Segment -
Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and
Other Heart Health Ingredients Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-76

Table 58: Rest of Europe Historic Review for Heart Health
Ingredients by Product Segment - Omega-3 PUFA, Soy Protein,
Phytosterols, Beta-Glucagon, and Other Heart Health
Ingredients Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-77

Table 59: Rest of Europe 15-Year Perspective for Heart
Health Ingredients by Product Segment - Percentage Breakdown
of Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols,
Beta-Glucagon, and Other Heart Health Ingredients Markets
for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-78

5. ASIA-PACIFIC III-79
A.Market Analysis III-79
Current & Future Analysis III-79
Regulatory Scenario in the Asia-Pacific Region III-79
India III-79
Market Scenario III-79
Soy Proteins Witness Robust Demand among Indian Consumers III-79
Product Launch III-80
Strategic Corporate Developments III-80
B.Market Analytics III-81
Table 60: Asia-Pacific Recent Past, Current and Future
Analysis for Heart Health Ingredients by Product Segment -
Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and
Other Heart Health Ingredients Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-81

Table 61: Asia-Pacific Historic Review for Heart Health
Ingredients by Product Segment - Omega-3 PUFA, Soy Protein,
Phytosterols, Beta-Glucagon, and Other Heart Health
Ingredients Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-82

Table 62: Asia-Pacific 15-Year Perspective for Heart Health
Ingredients by Product Segment - Percentage Breakdown of
Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols,
Beta-Glucagon, and Other Heart Health Ingredients Markets
for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-83

6. REST OF WORLD III-84
A.Market Analysis III-84
Current & Future Analysis III-84
Product Launch III-84
Strategic Corporate Development III-84
Lycored Limited - A Major Israeli Player III-85
B.Market Analytics III-86
Table 63: Rest of World Recent Past, Current and Future
Analysis for Heart Health Ingredients by Product Segment -
Omega-3 PUFA, Soy Protein, Phytosterols, Beta-Glucagon, and
Other Heart Health Ingredients Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-86

Table 64: Rest of World Historic Review for Heart Health
Ingredients by Product Segment - Omega-3 PUFA, Soy Protein,
Phytosterols, Beta-Glucagon, and Other Heart Health
Ingredients Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-87

Table 65: Rest of World 15-Year Perspective for Heart Health
Ingredients by Product Segment - Percentage Breakdown of
Dollar Sales for Omega-3 PUFA, Soy Protein, Phytosterols,
Beta-Glucagon, and Other Heart Health Ingredients Markets
for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-88

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 56 (including Divisions/Subsidiaries - 64)

The United States (33)
Canada (4)
Europe (19)
- Germany (1)
- The United Kingdom (3)
- Spain (1)
- Rest of Europe (14)
Asia-Pacific (Excluding Japan) (4)
Latin America (1)
Middle-East (3)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos